Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States

By Anis Aslam H.   Bansback Nick   Sizto Sonia   Gupta Shiraz R.   Willian Mary K.   Feldman Steve R.  

Journal of Dermatological Treatment, Vol. 22, Iss. 2, 2011-04 ,pp. : 65-74

Informa Healthcare

Access to resources Recommend Favorite

Reliability and validity of the psoriasis symptom inventory in patients with moderate-to-severe psoriasis

By Revicki Dennis A.   Jin Ying   Wilson Hilary D.   Chau Dina   Viswanathan Hema N.  

Journal of Dermatological Treatment, Vol. 25, Iss. 1, 2014-02 ,pp. : 8-14

Informa Healthcare

Access to resources Recommend Favorite

Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis

By Martin Silas   Feldman Steven R.   Augustin Matthias   Szapary Philippe   Schenkel Brad  

Journal of Dermatological Treatment, Vol. 22, Iss. 3, 2011-06 ,pp. : 138-143

Informa Healthcare

Access to resources Recommend Favorite

Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis

By Sommer Dorothea   Jenisch Stefan   Suchan Michael   Christophers Enno   Weichenthal Michael  

Archives of Dermatological Research, Vol. 298, Iss. 7, 2006-12 ,pp. : 321-328

Springer Publishing Company

Access to resources Recommend Favorite

Qualitative assessment of the content validity of the Dermatology Life Quality Index in patients with moderate to severe psoriasis

By Safikhani Shima  

Journal of Dermatological Treatment, Vol. 24, Iss. 1, 2013-02 ,pp. : 50-59

Informa Healthcare

Access to resources Recommend Favorite